TREATMENT OF EGFR MUTANT-RELATED CANCERS USING A COMBINATION OF EGFR AND CDK4/6 INHIBITORS
Publication
EP4034121A1
Kind: A1
Mar 18, 2026
Applicants
Beta Pharma, Inc.
Inventors
GRECO, Michael, Nicholas, COSTANZO, Michael, John, GREEN, Michael, Alan, ZHANG, Don, PENG, Jirong
IPC Classifications
A61K 31/505 20060101AFI20230912BHEP
A61P 35/00 20060101ALI20230912BHEP
A61K 31/517 20060101ALI20230912BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR